The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...
Enolen is currently being studied in a Phase 1 trial evaluating its safety, tolerability and preliminary efficacy for localized sustained delivery of enzalutamide into the prostate. Alessa expects to ...
The Punch on MSN
Emergence of HIFU treatment for prostate cancer, tumours, a game-changer – Specialists
Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...
Hosted on MSN
Key Information For Patients To Evaluate Prostate Cancer Treatment Options: Stage & Type Matter
Every prostate cancer journey begins with a clear understanding of the diagnosis. This isn’t a “one-size-fits-all” disease, and treatment plans are highly personalized. “When we’re evaluating a case ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback